Clinical Options Inc is categorized under Commercial Medical Research in Chicago, IL and active since 1998.
Clinical Options Inc was established in 1998, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 6213400 by the NAICS.
If you are seeking more information, feel free to contact Sherry Janousky, President at the company’s single location by writing to 2039 West Moffat St, Chicago, Illinois IL 60647 or by phoning (773) 486-2453. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clinical Options Inc |
| Contact Person: | Sherry Janousky, President |
| Address: | 2039 West Moffat St, Chicago, Illinois 60647 |
| Phone Number: | (773) 486-2453 |
| Website Address: | clinicaloptions.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1998 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 6213400 |
| Share This Business: |
Clinical Options Inc was started in 1998 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 6213400. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Sherry Janousky, President for inquiries that concern Clinical Options Inc by calling the company number (773) 486-2453, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical Options Inc can be found at the coordinates 41.915342,-87.679192 as well as the street address 2039 West Moffat St in Chicago, Illinois 60647.
For its online presence, you may visit Clinical Options Inc’s website at clinicaloptions.com and engage with its social media outlets through on Twitter and on Facebook.